ScholarIQanswers from OpenAlex

Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer

PaperCitations, authors & open-access status

Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer have?

ScholarIQcitation count

Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer has 57 citations in the OpenAlex counts ScholarIQ stores.

When was Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer published?

ScholarIQyear

Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer?

ScholarIQoa status

Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer has closed oa status in the ScholarIQ index.

What is the DOI of Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer?

ScholarIQdoi

The DOI for Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer is on the source record.

What is the PMID of Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer?

ScholarIQpmid

The PMID for Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer is on the source record.

What is the OpenAlex record for Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer?

ScholarIQopenalex

The OpenAlex for Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial